Properties (56)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Ranbaxy_Laboratories
|
| gptkbp:advertising |
focus on emerging markets
expansion in developed markets |
| gptkbp:awards |
Best Employer Award
Innovation in Pharma Award Pharma_Company_of_the_Year |
| gptkbp:CEO |
gptkb:Dilip_Shanghvi
|
| gptkbp:clinicalTrials |
ongoing for multiple products
|
| gptkbp:community_outreach |
awareness programs
support for local health initiatives health camps |
| gptkbp:drugInterdiction |
invests heavily in R&D
|
| gptkbp:employees |
over 30,000
|
| gptkbp:financialPerformance |
strong profit margins
consistent growth dividend paying company |
| gptkbp:founded |
1983
|
| gptkbp:founder |
gptkb:Dilip_Shanghvi
|
| gptkbp:global_presence |
over 100 countries
|
| gptkbp:headquarters |
gptkb:Mumbai,_India
|
| https://www.w3.org/2000/01/rdf-schema#label |
SUNPHARMA
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:investmentFocus |
transparent communication
regular updates on performance |
| gptkbp:market |
approximately $30 billion (2021)
|
| gptkbp:partnerships |
various global pharmaceutical companies
|
| gptkbp:productionLocation |
multiple locations worldwide
|
| gptkbp:products |
generic drugs
branded drugs active pharmaceutical ingredients (APIs) |
| gptkbp:regulatoryCompliance |
WHO approved
FDA_approved EMA_approved |
| gptkbp:research_areas |
diabetes
cardiology neurology oncology psychiatry dermatology pain management urology gastroenterology respiratory |
| gptkbp:researchAndDevelopment |
focus on complex generics
|
| gptkbp:revenue |
$4.5 billion (2021)
|
| gptkbp:social_responsibility |
disaster relief efforts
education programs healthcare_access_initiatives |
| gptkbp:stockExchange |
gptkb:BSE
NSE |
| gptkbp:subsidiary |
gptkb:Taro_Pharmaceutical_Industries
|
| gptkbp:sustainability_initiatives |
community engagement
employee welfare environmental responsibility |
| gptkbp:website |
www.sunpharma.com
|